ASX:UCM

Uscom Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

VolumeN/A

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive UCM News and Ratings via Email

Sign-up to receive the latest news and ratings for Uscom and its competitors with MarketBeat's FREE daily newsletter.

About Uscom

Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices worldwide. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function using Doppler ultrasound; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, as well as in the arm; and SpiroSonic, a pulmonary function testing device based on multi-path ultrasound technology. The company provides Ventitest, a ventilator testing device; Ventitest sensor to test lung function; and The SpiroSonic AIR, a digital home care spirometer which feeds digital lung function signals through a phone app. It serves hospitals and other medical care locations through a network of distribution partners. The company was incorporated in 1999 and is headquartered in Sydney, Australia.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Stock Exchange: ASX
Industry: Medical Devices
Sub-Industry: N/A
Sector: Medical
Current Symbol: ASX:UCM
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: www.uscom.com.au
Phone: 61 2 9247 4144
Employees: N/A
Year Founded: N/A

Sales & Book Value

Annual Sales: $4.55 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: A$0.02 per share
Price / Book: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 46.46
Current Ratio: 3.64
Quick Ratio: 2.69

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: N/A
Market Cap: N/A
Next Earnings Date: N/A
Optionable: Not Optionable

MarketRank^™

Overall MarketRank^™

0.88 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Uscom.

4.4 Community Rank

Outperform Votes
Uscom has received 4 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Uscom has received 2 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Uscom has received 66.67% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Uscom and other stocks. Vote “Outperform” if you believe UCM will outperform the S&P 500 over the long term. Vote “Underperform” if you believe UCM will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Uscom does not currently pay a dividend.
Dividend Growth
Uscom does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Uscom insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Uscom (ASX:UCM) Frequently Asked Questions

What stocks does MarketBeat like better than Uscom?: Wall Street analysts have given Uscom a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Uscom wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.
Who are Uscom's key executives?: Uscom's management team includes the following people:
Dr. Robert Allan Phillips DMU, Ph.D.(Med), AMS, MPhil (Med), FASE, FIR, Founder, Exec. Chairman, CEO & Chief Scientist (Age 68, Pay $275.17k)
Mr. Brett Crowley B.Com., C.A., BCom, DipLaw, CA, Company Sec. & Non-Exec. Director (Age 64, Pay $38.28k)
Mr. Nicholas Schicht, Gen. Mang. (Age 55, Pay $213.16k)
Who are some of Uscom's key competitors?: Some companies that are related to Uscom include 4DMedical (4DX), Adherium (ADR), ADM Tronics Unlimited (ADMT), Allegra Orthopaedics (AMT), Analytica (ALT), AnteoTech (ADO), Anteris Technologies (AVR), Asensus Surgical (ASXC), Atomo Diagnostics (AT1), AVITA Medical (AVH), Azure Healthcare Limited (AZV.AX) (AZV), Cannabix Technologies (BLO), CleanSpace (CSX), Cochlear (COH) and Cochlear (CHEOY).
View all of UCM's competitors.
What is Uscom's stock symbol?: Uscom trades on the ASX under the ticker symbol "UCM."
How much money does Uscom make?: Uscom has a market capitalization of $0.00 and generates $4.55 million in revenue each year.
What is Uscom's official website?: The official website for Uscom is www.uscom.com.au.
How can I contact Uscom?: The company can be reached via phone at 61 2 9247 4144.

This page was last updated on 10/16/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.